Eric Walker added Secretary Azar can't wait to address antibiotic resistance | TheHill to Antibiotic resistance and pharmaceutical business models, Alex Azar and the US Department of Health and Human Services and Antimicrobial resistance in the United States

Eric Walker added Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a Seat to Antibiotic resistance and pharmaceutical business models and Antimicrobial stewardship

Eric Walker added Racing the clock to stop drug-resistant superbugs - The Boston Globe to Antibiotic resistance and pharmaceutical business models, Kevin Outterson and CARB-X and CARB-X

Eric Walker added Commentary: How COVID-19 has added to the problem of drug-resistant antibiotics - Chicago Tribune to a number of topics

Eric Walker added As a virus ravages the world, antibiotic makers are in disarray | PBS NewsHour to a number of topics

Eric Walker added The U.S. Is Not Prepared to Combat 'Existential Threat' of Antibiotic-Resistant Superbugs | The Pew Charitable Trusts to Antibiotic resistance and pharmaceutical business models

Eric Walker added UK launches scheme to encourage development of novel antibiotics to Antibiotic resistance and pharmaceutical business models

Eric Walker added AMR: new business model for antibiotics development urgently needed to Antibiotic resistance and pharmaceutical business models and European Union (EU)

Eric Walker added Doctors Heavily Overprescribed Antibiotics Early in the Pandemic - The New York Times to a number of topics

Eric Walker added Coronavirus Pandemic Highlights Need to Spur Antibiotic Innovation | The Pew Charitable Trusts to Covid-19 and antimicrobial resistance and Antibiotic resistance and pharmaceutical business models

Eric Walker added Congressional watchdog advises HHS to implement ‘post-marketing’ incentives to address dwindling antibiotic development efforts – Endpoints News to Covid-19 and antimicrobial resistance and Antibiotic resistance and pharmaceutical business models

Eric Walker added Covid-19 May Worsen the Antibiotic Resistance Crisis | WIRED to Covid-19 and antimicrobial resistance, Antibiotic resistance and pharmaceutical business models and 2009 Swine flu pandemic

Eric Walker added Socialize Big Pharma Today. Save Your Life Tomorrow. to Antibiotic resistance and pharmaceutical business models, 2020-02 MIT study reporting a new antibiotic discovered using machine learning and Social democracy

Eric Walker added The Invaluable Role of Antibiotics—in a Pandemic and Beyond | The Pew Charitable Trusts to Covid-19 and antimicrobial resistance and Antibiotic resistance and pharmaceutical business models

Eric Walker added Tracking the Global Pipeline of Antibiotics in Development, April 2020 | The Pew Charitable Trusts to Antibiotic resistance and pharmaceutical business models

Eric Walker added Analysis highlights troubles in the antibiotic pipeline | CIDRAP to Antibiotic resistance and pharmaceutical business models and Cefepime-enmetazobactam

Eric Walker added The global antibiotic crisis: a 2020 perspective - PMLiVE to DISARM Act model legislation, Antibiotic resistance and pharmaceutical business models and AMR Centre

Eric Walker added Antibiotic resistance: the hidden threat lurking behind Covid-19 - STAT to Covid-19 and antimicrobial resistance, DISARM Act model legislation and Antibiotic resistance and pharmaceutical business models

Eric Walker added Saving lives should be good business. Why doesn’t that apply to finding new antibiotics? - STAT to DISARM Act model legislation and Antibiotic resistance and pharmaceutical business models

Eric Walker added A complex solution is possible for antimicrobial resistance, EAM finds | Science|Business to Antibiotic resistance and pharmaceutical business models

Eric Walker added Stewardship vs. Financial Incentives: A False Choice | American Council on Science and Health to Antibiotic resistance and pharmaceutical business models

Eric Walker added Why Antibiotic Resistance Is Ignored by Big Pharma to Antibiotic resistance and pharmaceutical business models

Eric Walker added Responsibly manufactured antimicrobials are a universal necessity - STAT to AMR Industry Alliance, Antibiotic resistance and pharmaceutical business models and 2019-05 University of York study on antibiotics in rivers

Eric Walker added Reliance on few drugmakers fuels superbug concerns | News | messenger-inquirer.com to Antibiotic resistance and pharmaceutical business models

Eric Walker added Why developing new antibiotics is a matter of life and death – The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com to Antibiotic resistance and pharmaceutical business models

Eric Walker added Race for new antibiotics: future success is hanging by a thread | Wellcome to Antibiotic resistance and pharmaceutical business models

Eric Walker added The challenge of new antibiotic discovery to Antibiotic resistance and pharmaceutical business models and Overviews of antibiotic resistance

Eric Walker added Tackling antimicrobial resistance on multiple fronts - PMLiVE to Antibiotic resistance and pharmaceutical business models

Eric Walker added Can we make the antibiotic market great again? – Endpoints News to Antibiotic resistance and pharmaceutical business models

Eric Walker added Superbugs Need Super Drugs...and Fast to Antibiotic resistance and pharmaceutical business models

Eric Walker added As Drug-Resistant Bacteria Frustrates Big Pharma, Impact Investors See Opportunities - Karma to Antibiotic resistance and pharmaceutical business models

Eric Walker added Pharma firms not making enough progress against superbugs: report - Reuters to Antibiotic resistance and pharmaceutical business models

Eric Walker added Access to antibiotics as much a concern as antimicrobial resistance, says report - The Hindu BusinessLine to Antibiotic resistance and pharmaceutical business models

Eric Walker added In Superbug War, Reliance on Just a Few Drugmakers Fuels Concern to Antibiotic resistance and pharmaceutical business models

Eric Walker added Antibiotic resistance: The threat is growing and the research is too slow | Science| In-depth reporting on science and technology | DW | 21.01.2020 to Antibiotic resistance and pharmaceutical business models

Eric Walker added Science flourishes when people are free to question authority, says Nobel Laureate Venkatraman Ramakrishnan - The Hindu to Antibiotic resistance and pharmaceutical business models and Muslims in India

Eric Walker added Lack of new antibiotics threatens global efforts to contain drug-resistant infections to a number of topics

Eric Walker added Sustainable Discovery and Development of Antibiotics — Is a Nonprofit Approach the Future? to Antibiotic resistance and pharmaceutical business models

Eric Walker added Opinion | Making Sure Our Antibiotics Remain Potent - The New York Times to Antibiotic resistance and pharmaceutical business models and Articles in the New York Times

Eric Walker added India should lead in the fight against multidrug-resistant pathogens - The Hindu to Antibiotic resistance and pharmaceutical business models and Antibiotic resistance genes (ARGs)

Eric Walker added Fighting ‘superbugs’ in Massachusetts (Guest viewpoint) - masslive.com to a number of topics

Eric Walker added Antibiotic developers are struggling to stay in business, increasing the risk of superbugs to Antibiotic resistance and pharmaceutical business models

Eric Walker added Antibiotic Marketing and Pipeline Shortages in the Era of Stewardship: An Industry Perspective to Antibiotic resistance and pharmaceutical business models

Eric Walker added Editorial: Frightening prospect | Editorials | nonpareilonline.com to DISARM Act model legislation, Antibiotic resistance and pharmaceutical business models and Antimicrobial resistance and government policy

Eric Walker added Antibiotic developer Melinta files for bankruptcy | CIDRAP to a number of topics

Eric Walker added Antibiotics innovators struggle to stay afloat to Antibiotic resistance and pharmaceutical business models

Eric Walker added Crisis Looms in Antibiotics as Drug Makers Go Bankrupt - The New York Times to a number of topics

Eric Walker added Opinion: Killer superbugs are coming for you - Los Angeles Times to Antibiotic resistance and pharmaceutical business models, Working to Fight AMR and Ceftriaxone

Eric Walker added New antibiotics: why we need them and what are they worth? to Antibiotic resistance and pharmaceutical business models

Eric Walker added Biopharma has abandoned antibiotic development | Hacker News to Antibiotic resistance and pharmaceutical business models